Trial Profile
A phase I study of HPP-971 for the treatment of inflammation.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2020
Price :
$35
*
At a glance
- Drugs ANT 401 (Primary)
- Indications Inflammation
- Focus Adverse reactions
- 15 Dec 2020 Status changed from recruiting to completed, according to vTv Therapeutics LLC media release.
- 01 Feb 2016 New trial record